Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.38 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALPL | P05186 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 4/20 | 0.36 |
| ▸ | PPARA | Q07869 | 4/20 | 0.36 |
| ▸ | FNTA | P49354 | 2/20 | 0.35 |
| ▸ | FNTB | P49356 | 2/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | TDO2 | P48775 | 1/20 | 0.35 |
| ▸ | IDO2 | Q6ZQW0 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4846877 | 0.85 | ALDH1A1 (0.50) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4 | |
| SCHEMBL16000086 | 0.76 | SLC6A4 (0.46) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4 | |
| SCHEMBL10906712 | 0.76 | IDO1 (0.40) | ALDH1A1IDO1TDO2IDO2 | |
| SCHEMBL19984489 | 0.73 | SLC6A4 (0.44) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4 | |
| SCHEMBL31519360 | 0.73 | ALDH1A1 (0.58) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4 | |
| SCHEMBL28591832 | 0.72 | DPP4 (0.58) | ALOX5ALDH1A1AKR1C3AKR1C2GPR84 | |
| SCHEMBL31186225 | 0.72 | ALOX5 (0.55) | ALOX5ALDH1A1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3003492 | 0.72 | ALOX5 (0.55) | ALOX5ALDH1A1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL25302086 | 0.72 | ALDH1A1 (0.59) | ALDH1A1CYP1A2PTPN1KDM4EALPL | |
| SCHEMBL29350007 | 0.72 | ALDH1A1 (0.59) | ALDH1A1CYP1A2PTPN1KDM4EALPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9873691-B2 | TRPV1 antagonists including dihydroxy substituent and uses thereof | PURDUE PHARMA L.P. (US) | 2018-01-23 | — | — | US | disclosed |
| US-20160318920-A1 | TRPV1 ANTAGONISTS INCLUDING DIHYDROXY SUBSTITUENT AND USES THEREOF | PURDUE PHARMA L.P. | 2016-11-03 | — | — | US | disclosed |
| US-9394293-B2 | TRPV1 antagonists including dihydroxy substituent and uses thereof | PURDUE PHARMA L.P. (US) | 2016-07-19 | — | — | US | disclosed |
| US-20140350056-A1 | TRPV1 ANTAGONISTS INCLUDING DIHYDROXY SUBSTITUENT AND USES THEREOF | PURDUE PHARMA L.P. | 2014-11-27 | — | — | US | disclosed |
| WO-2013021276-A1 | TRPV1 ANTAGONISTS INCLUDING DIHYDROXY SUBSTITUENT AND USES THEREOF | PURDUE PHARMA L.P. (US) | 2013-02-14 | — | — | WO | disclosed |
| US-8129388-B2 | Therapeutic agents useful for treating pain | Purde Pharma L.P. (US) | 2012-03-06 | — | — | US | disclosed |
| US-20110288100-A1 | THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN | PURDUE PHARMA L.P. (US) | 2011-11-24 | — | — | US | disclosed |
| US-20110281876-A1 | THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN | PURDUE PHARMA L.P. (US) | 2011-11-17 | — | — | US | disclosed |
| US-8030310-B2 | Therapeutic agents useful for treating pain | PURDUE PHARMA, L.P. (US) | 2011-10-04 | — | — | US | disclosed |
| EP-1942106-B1 | Therapeutic agents useful for treating pain | EURO CELTIQUE SA (LU) | 2011-09-14 | — | — | EP | disclosed |
| EP-1487829-A1 | THIADIAZOLYLPIPERAZINE DERIVATIVES USEFUL FOR TREATING OR PREVENTING PAIN | Euro-Celtique S.A. (LU) | 2004-12-22 | — | — | EP | disclosed |
| US-20040235853-A1 | Therapeutic agents useful for treating pain | PURDUE PHARMA L.P. | 2004-11-25 | — | — | US | disclosed |
| WO-2004029031-A2 | THERAPEUTIC PIPERAZINE COMPOUNDS | EURO-CELTQUE, S.A. (LU) | 2004-04-08 | — | — | WO | disclosed |
| US-20040044003-A1 | Therapeutic agents useful for treating pain | PURDUE PHARMA L.P. | 2004-03-04 | — | — | US | disclosed |
| WO-2004011441-A1 | PYRIDAZINYLPIPERAZINE DERIVATIVES FOR TREATING PAIN | EURO-CELTIQUE S.A. (LU) | 2004-02-05 | — | — | WO | disclosed |
| EP-1383505-A2 | INOSINE COMPOUNDS AND THEIR USE FOR TREATING OR PREVENTING AN INFLAMATION OR A REPERFUSION DISEASE | Inotek Pharmaceuticals Corporation (US) | 2004-01-28 | — | — | EP | disclosed |
| US-20040006091-A1 | Therapeutic agents useful for treating or preventing pain | PURDUE PHARMA L.P. | 2004-01-08 | — | — | US | disclosed |
| WO-2003074520-A1 | THIADIAZOLYLPIPERAZINE DERIVATIVES USEFUL FOR TREATING OR PREVENTING PAIN | EURO-CELTIQUE, S.A. (LU) | 2003-09-12 | — | — | WO | disclosed |
| US-20030040502-A1 | Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease | INOTEK PHARMACEUTICALS CORPORATION | 2003-02-27 | — | — | US | disclosed |
| WO-2002076400-A2 | INOSINE COMPOUNDS AND THEIR USE FOR TREATING OR PREVENTING AN INFLAMATION OR A REPERFUSION DISEASE | INOTEK PHARMACEUTICALS CORPORATION (US) | 2002-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110281876-A1 | THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN | OPRL1, OPRK1, TRPV1 | ALOX5 695/4885ALDH1A1 407/4885CYP1A2 2126/4885 |
| US-20040006091-A1 | Therapeutic agents useful for treating or preventing pain | OPRK1, OPRL1, OPRD1 | ALOX5 110/4885ALDH1A1 742/4885CYP1A2 1411/4885 |
| US-20030040502-A1 | Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease | NOS2, NOS1, ARG2 | ALOX5 216/4885ALDH1A1 1330/4885CYP1A2 3132/4885 |
| US-20160318920-A1 | TRPV1 ANTAGONISTS INCLUDING DIHYDROXY SUBSTITUENT AND USES THEREOF | TRPV1, TRPV2, TRPA1 | ALOX5 526/4885ALDH1A1 336/4885CYP1A2 540/4885 |
| US-20110288100-A1 | THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN | OPRL1, OPRK1, MTNR1A | ALOX5 409/4885ALDH1A1 652/4885CYP1A2 1359/4885 |
| US-20140350056-A1 | TRPV1 ANTAGONISTS INCLUDING DIHYDROXY SUBSTITUENT AND USES THEREOF | TRPV1, TRPV2, TRPA1 | ALOX5 526/4885ALDH1A1 336/4885CYP1A2 540/4885 |
| US-20040235853-A1 | Therapeutic agents useful for treating pain | OPRM1, OPRL1, ALPI | ALOX5 479/4885ALDH1A1 687/4885CYP1A2 1601/4885 |
| US-20040044003-A1 | Therapeutic agents useful for treating pain | GRIK5, HBS1L, GABRR1 | ALOX5 564/4885ALDH1A1 1203/4885CYP1A2 2974/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.